earnings
confidence high
sentiment positive
materiality 0.75
P3 Health Partners Q3 revenue $288.4M (+16% YoY); net loss narrows; guides for positive 2024 Adj EBITDA
P3 Health Partners Inc.
2023-Q3 EPS reported
-$0.41
revenue$919,514,000
- Q3 total revenue $288.4M, up 16% YoY; net loss $37.3M vs. $65.3M loss prior year.
- Adjusted EBITDA loss $22.3M, improved from $40.3M loss YoY; medical margin $36.2M, +306%.
- YTD total revenue $919.5M (+16%); net loss $117.3M vs. $1,029.2M loss (incl. $851M goodwill impairment).
- Reaffirms FY 2023 guidance: revenue $1.2B-$1.25B, Adj EBITDA loss $(50)-$(30)M; MA members 115k-120k.
- Preliminary FY 2024 Adj EBITDA guidance of +$20M to +$40M, signaling expected profitability.